MoonLake Immunotherapeutics (MLTX) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Zug, 瑞士. 现任CEO为 Jorge Santos da Silva.
MLTX 拥有 IPO日期为 2020-10-20, 100 名全职员工, 在 NASDAQ Capital Marke, 市值为 $1.35B.
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.
